MEK inhibition as a strategy for targeting residual breast cancer cells with low DUSP4 expression

por Rottenberg, Sven, Jonkers, Jos
Publicado 2012

Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response

por Francica, Paola, Rottenberg, Sven
Publicado 2018

New tools for old drugs: Functional genetic screens to optimize current chemotherapy

por Gerhards, Nora M., Rottenberg, Sven
Publicado 2018

Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers

por Liptay, Martin, Barbosa, Joana S., Rottenberg, Sven
Publicado 2020

Meiotic Genes and DNA Double Strand Break Repair in Cancer

por Lingg, Lea, Rottenberg, Sven, Francica, Paola
Publicado 2022

Functional genetic dropout screens and in vivo validation of candidate therapeutic targets using mouse mammary tumoroids

por Paes Dias, Mariana, Rottenberg, Sven, Jonkers, Jos
Publicado 2022

Identification and characterisation of a Theileria annulata proline‐rich microtubule and SH3 domain‐interacting protein (TaMISHIP) that forms a complex with CLASP1, EB1, and CD2AP...

por Huber, Sandra, Karagenc, Tulin, Ritler, Dominic, Rottenberg, Sven, Woods, Kerry
Publicado 2018

Identifying subgroup markers in heterogeneous populations

por de Ronde, Jorma J., Rigaill, Guillem, Rottenberg, Sven, Rodenhuis, Sjoerd, Wessels, Lodewyk F. A.
Publicado 2013

CRISPR/Cas9-Mediated Targeting of BPV-1-Transformed Primary Equine Sarcoid Fibroblasts

por Monod, Anne, Koch, Christoph, Jindra, Christoph, Haspeslagh, Maarten, Howald, Denise, Wenker, Christian, Gerber, Vinzenz, Rottenberg, Sven, Hahn, Kerstin
Publicado 2023

Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonanc...

por van Asten, Jack JA, Vettukattil, Riyas, Buckle, Tessa, Rottenberg, Sven, van Leeuwen, Fijs, Bathen, Tone F, Heerschap, Arend
Publicado 2015

LRP6 Is a Functional Receptor for Attenuated Canine Distemper Virus

por Gradauskaite, Vaiva, Inglebert, Marine, Doench, John, Scherer, Melanie, Dettwiler, Martina, Wyss, Marianne, Shrestha, Neeta, Rottenberg, Sven, Plattet, Philippe
Publicado 2023

EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors

por Zander, Serge A. L., Sol, Wendy, Greenberger, Lee, Zhang, Yixian, van Tellingen, Olaf, Jonkers, Jos, Borst, Piet, Rottenberg, Sven
Publicado 2012

Monitoring of Tumor Response to Cisplatin Using Optical Spectroscopy

por Spliethoff, Jarich W., Evers, Daniel J., Jaspers, Janneke E., Hendriks, Benno H.W., Rottenberg, Sven, Ruers, Theo J.M.
Publicado 2014

Haploid genetic screens identify genetic vulnerabilities to microtubule‐targeting agents

por Gerhards, Nora M., Blomen, Vincent A., Mutlu, Merve, Nieuwenhuis, Joppe, Howald, Denise, Guyader, Charlotte, Jonkers, Jos, Brummelkamp, Thijn R., Rottenberg, Sven
Publicado 2018

A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer

por Inglebert, Marine, Dettwiler, Martina, Hahn, Kerstin, Letko, Anna, Drogemuller, Cord, Doench, John, Brown, Adam, Memari, Yasin, Davies, Helen R., Degasperi, Andrea, Nik-Zainal, Serena, Rottenberg, Sven
Publicado 2022

The prognostic value of tumor-stroma ratio and a newly developed computer-aided quantitative analysis of routine H&E slides in high-grade serous ovarian cancer

por van wagensveld, lilian, Walker, Cedric, Hahn, Kerstin, Sanders, Joyce, Kruitwagen, Roy, van der Aa, Maaike, Sonke, Gabe, Rottenberg, Sven, de Vijver, Koen Van, Janowczyk, Andrew, Horlings, Hugo
Publicado 2023

Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin

por Pang, Baoxu, Qiao, Xiaohang, Janssen, Lennert, Velds, Arno, Groothuis, Tom, Kerkhoven, Ron, Nieuwland, Marja, Ovaa, Huib, Rottenberg, Sven, van Tellingen, Olaf, Janssen, Jeroen, Huijgens, Peter, Zwart, Wilbert, Neefjes, Jacques
Publicado 2013

Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cells

por Schoonen, Pepijn M., Talens, Francien, Stok, Colin, Gogola, Ewa, Heijink, Anne Margriet, Bouwman, Peter, Foijer, Floris, Tarsounas, Madalena, Blatter, Sohvi, Jonkers, Jos, Rottenberg, Sven, van Vugt, Marcel A. T. M.
Publicado 2017

Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model

por Borst, Gerben R., Kumareswaran, Ramya, Yücel, Hatice, Telli, Seyda, Do, Trevor, McKee, Trevor, Zafarana, Gaetano, Jonkers, Jos, Verheij, Marcel, O’Connor, Mark J., Rottenberg, Sven, Bristow, Robert G.
Publicado 2017

Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model

por Borst, Gerben R., Kumareswaran, Ramya, Yücel, Hatice, Telli, Seyda, Do, Trevor, McKee, Trevor, Zafarana, Gaetano, Jonkers, Jos, Verheij, Marcel, O’Connor, Mark J., Rottenberg, Sven, Bristow, Robert G.
Publicado 2020